BioMed Research International

Optimal Use of Biomarkers in Oncology


Publishing date
13 Mar 2015
Status
Published
Submission deadline
24 Oct 2014

Lead Editor

1Charles University in Prague, Prague, Czech Republic

2Hebrew University, Jerusalem, Israel

3Clinical Consultants Inc., Ridgewood, USA


Optimal Use of Biomarkers in Oncology

Description

The use of biomarkers in oncology has been much more extensive than in other diseases for more than 30 years. Their use has evolved beyond the research laboratory to more routine clinical use as in diagnosis, monitoring of disease status, and treatment efficacy.

With the advances in molecular biology, other biomarkers than the "classical" serum markers are being developed for clinical use: gene mutations, microRNA, circulating tumor cells, circulating DNA, and others currently in research. Biomarkers such as these are currently being used for prediction potential “at risk” for disease as well as response to therapy (predictive biomarkers) and for disease prognosis (prognostic biomarkers).

In oncological routine, the correlation of biomarker levels with the clinical status and medical imaging methods is of great significance. The purpose of the correlation is twofold: providing a sequential and/or more specific diagnostics and keeping these procedures within affordable economical limits.

We invite research scientists and other investigators to contribute original research articles as well as review articles that address the optimal use of biomarkers in oncology.

Potential topics include, but are not limited to:

  • Biomarkers measurement and their impact on the disease state (diagnostics and followup)
  • Circulation tumor cells and circulation tumor DNA as prognostic and predictive markers
  • MicroRNA as prognostic markers in cancer
  • Molecular markers to predict clinical outcome and toxicity in cancer
  • Biomarkers for the selection of therapy, prediction, and monitoring
  • Genetics and biomarkers in personalization of cancer treatment
  • Correlation of biomarkers and medical imaging
  • Perspectives on the use of biomarkers in oncology

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 423159
  • - Editorial

Optimal Use of Biomarkers in Oncology

Marie Karlikova | Ondrej Topolcan | ... | Tomas Zima
  • Special Issue
  • - Volume 2015
  • - Article ID 345219
  • - Review Article

Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment

Susumu Kageyama | Eiki Hanada | ... | Akihiro Kawauchi
  • Special Issue
  • - Volume 2015
  • - Article ID 103515
  • - Review Article

Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis

Yijuan Cao | Zengyan Wang | ... | Bin Quan
  • Special Issue
  • - Volume 2015
  • - Article ID 475920
  • - Review Article

Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate Cancer

Jeong Hyun Kim | Sung Kyu Hong
  • Special Issue
  • - Volume 2015
  • - Article ID 824514
  • - Review Article

Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management

Tatsha C. Bholah | Vidushi S. Neergheen-Bhujun | ... | Theeshan Bahorun
  • Special Issue
  • - Volume 2015
  • - Article ID 792187
  • - Review Article

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia

Michal Rihacek | Julie Bienertova-Vasku | ... | Lenka Zdrazilova-Dubska
  • Special Issue
  • - Volume 2015
  • - Article ID 237863
  • - Research Article

Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion Classification

Roberta Fusco | Mario Sansone | ... | Antonella Petrillo
  • Special Issue
  • - Volume 2015
  • - Article ID 896432
  • - Review Article

hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers

Elena Lastraioli | Tiziano Lottini | ... | Annarosa Arcangeli
  • Special Issue
  • - Volume 2015
  • - Article ID 485732
  • - Research Article

Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation

Maria Tolia | Nikolaos Tsoukalas | ... | Vassilis Kouloulias
  • Special Issue
  • - Volume 2015
  • - Article ID 986024
  • - Clinical Study

Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer

Søren Kristiansen | Lars Mønster Jørgensen | ... | György Sölétormos
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision83 days
Acceptance to publication45 days
CiteScore2.410
Impact Factor2.197
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.